Hims & Hers review
Mainstream, app-first
A mainstream consumer brand with an app-first weight program built around compounded GLP-1 and ongoing support.
Our verdict
Hims & Hers is the recognizable, app-first choice — a slick mobile experience and ongoing clinical support around compounded semaglutide and tirzepatide. It's cash-pay in our data and doesn't publish an all-in price up front, so treat it as a convenience-and-brand play rather than a cost leader.
Disclosure: Aminoscope is reader-supported. Some links below are affiliate links — if you start care through them we may earn a commission, at no extra cost to you. This never affects our rankings or verdicts. How we make money.
At a glance
- Category
- GLP-1 telehealth
- Medications
- Semaglutide · Tirzepatide
- Insurance
- Cash-pay, no insurance
- Visit
- Video visit / Async intake
- Updated
- July 2026
Popular alternative
Enhance MD
Lab-guided treatment under ongoing physician oversight
Check Enhance MD availability →What it is
Hims & Hers is a widely used consumer telehealth brand whose weight-management track offers GLP-1 medication with ongoing clinical support, delivered through a heavily app-based experience.
How it works
The experience is built around the app — video or asynchronous visits, prescribing, refills, and check-ins all run through it. That's convenient and familiar, but it's a consumer-brand model rather than a dedicated obesity-medicine practice.
Pricing transparency
Hims doesn't publish a clear all-in GLP-1 price before intake in our data, and it's a cash-pay service — no insurance billing. Confirm the full monthly cost, including how it changes as your dose climbs, before committing.
Branded vs compounded
Our provider data lists compounded semaglutide and tirzepatide for the weight track — these are compounding-pharmacy products, not the FDA-approved branded drugs. Confirm the exact medication and its source during intake before you start.
Pros and watch-outs
What we like
- Polished, app-first experience from a mainstream brand
- Ongoing clinical support, not a one-off script
- Video and asynchronous visit options
- Familiar, widely-used consumer platform
Watch-outs
- Cash-pay — no insurance billing in our data
- All-in pricing isn't published up front
- Compounded medication, not FDA-approved branded
Best for
People who want a familiar, app-driven experience from a mainstream brand and don't need insurance billing.
Who should look elsewhere
Anyone who wants branded medication, insurance coverage, or fully upfront pricing.
How Hims & Hers compares
A few alternatives worth a look, depending on what you’re optimizing for.
RoA polished, well-resourced end-to-end program
See Ro →
FoundPutting insurance benefits toward GLP-1 treatment
See Found →
Mochi HealthA clinician-led, titration-focused program
See Mochi Health →
Access & cost · Reviewed and last verified July 2026
How we assessed this. This review reflects Aminoscope’s own read of Hims & Hers’s publicly-stated model — pricing transparency, clinical oversight, medication clarity, and access — against our editorial methodology. We publish no fabricated ratings or first-hand outcomes. A partnership never changes the assessment — see how we make money.
Frequently asked
- Does Hims take insurance for weight loss?
- In our data Hims runs a cash-pay model for the GLP-1 weight track, so there's no insurance billing. If using insurance benefits matters to you, a provider like Ro or Found is a better starting point.
- Does Hims offer branded or compounded GLP-1?
- Our provider data lists compounded semaglutide and tirzepatide for the weight track — compounding-pharmacy products, not the FDA-approved branded drugs. Confirm the exact medication and its source during intake.
- How much does the Hims weight program cost?
- Hims doesn't publish a clear all-in GLP-1 price before intake in our data. Confirm the full monthly cost, including how it steps up at higher doses, during the intake.